Science

Amgen pipeline

Amgen has created a robust and differentiated pipeline, leveraging state-of-the-art science to create medicines for serious illnesses.

Introduction in biotechnology

Amgen was one of the first companies to recognize the potential of modern biotechnology in developing valuable medicines for patients. Today’s biologic medicines have made a significant difference to the lives of patients with serious illnesses.

Immuno-oncology: The next generation of cancer treatment

The immune system is a powerful weapon against cancer. Find out here how the body’s defense mechanism is used in cancer therapy.

Clinical research

One of the most important steps in the long and careful process of developing new therapies are clinical trials. These involve people volunteering to receive a new therapy and its effects being investigated.

Amgen biosimilars

Biosimilars offer the potential to increase patient access to vital medicines. Amgen is well positioned to leverage its more than 40 years of experience in biotechnology to create high-quality biosimilars and reliably supply them to patients worldwide.

Biomarkers: The key to transforming lung cancer treatment

Lung cancer is not "one disease": there are different types and each type of lung cancer is different. Read more why biomarker testing is recommended.